730272 - Repligen Corp - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - RGEN (730272)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
49 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S9+1+0+1+16

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-07-18
RGENSnodgres JonCFOF - Tax$41.77-34527,444-1%-$14,411
D
2017-05-18
RGENRyan Thomas F JrDirA - Grant$0.00+1,2068,700+16%+$0
D
2017-05-18
RGENMuir Glenn PDirA - Grant$0.00+1,2062,969+68%+$0
D
2017-05-18
RGENCox JohnDirA - Grant$0.00+1,2064,827+33%+$0
D
2017-05-18
RGENCooper Glenn L MdDirA - Grant$0.00+1,20638,300+3%+$0
D
2017-05-18
RGENBarthelemy NicolasDirA - Grant$0.00+1,2063,988+43%+$0
D
2017-05-18
RGENDawes Karen ADirA - Grant$0.00+1,71494,957+2%+$0
2017-05-10
RGENHunt AnthonyCEOF - Tax$37.97-2,27592,583-2%-$86,393+1
2017-03-29
RGENRyan Thomas F JrDirG - Gift$0.00-1,1007,494-13%-$00-4+6
D
2017-03-21
RGENDawes Karen ADirS - Sale+OE$34.12-2,52193,243-3%-$86,017+2+2+5
D
2017-03-21
RGENDawes Karen ADirM - OptEx$4.29+20,00093,243+27%+$85,800+2+2+5
D
2017-03-20
RGENBenjamin HowardVP Business DevelopmentS - Sale+OE$34.62-12,21633,908-26%-$422,954+2+2+5
D
2017-03-20
RGENBenjamin HowardVP Business DevelopmentM - OptEx$9.44+14,96833,908+79%+$141,341+2+2+5
D
2017-03-20
RGENRyan Thomas F JrDirS - Sale+OE$34.83-4,0008,594-32%-$139,321+2+2+5
D
2017-03-20
RGENRyan Thomas F JrDirM - OptEx$3.22+4,0008,594+87%+$12,880+2+2+5
D
2017-03-17
RGENSnodgres JonCFOS - Sale+OE$34.91-1,90927,789-6%-$66,646+1+2+6
D
2017-03-17
RGENSnodgres JonCFOM - OptEx$24.50+4,00027,789+17%+$98,000+1+2+6
D
2017-03-01
RGENBenjamin HowardVP Business DevelopmentF - Tax$32.08-1,97631,156-6%-$63,387-1-3+10
D
2017-02-23
RGENBenjamin HowardVP Business DevelopmentA - Grant$0.00+4,50631,156+17%+$0-1-3+10
D
2017-03-01
RGENSnodgres JonCFOF - Tax$32.07-1,63025,698-6%-$52,273-1-3+10
D
2017-02-23
RGENSnodgres JonCFOA - Grant$0.00+9,87525,698+62%+$0-1-3+10
D
2017-03-01
RGENHunt AnthonyCEOF - Tax$32.07-5,97294,858-6%-$191,524-1-3+10
D
2017-02-23
RGENHunt AnthonyCEOA - Grant$0.00+32,48894,858+52%+$0-1-3+10
2016-11-28
RGENHunt AnthonyCEOS - Sale$33.12-5,00068,342-7%-$165,613-4-4-6
2016-09-14
RGENRyan Thomas F JrDirS - Sale$32.58-2,7009,394-22%-$87,9790-1-11+6
2016-07-14
RGENSnodgres JonCFOF - Tax$26.56-32417,453-2%-$8,6050+1+15+15
2016-07-14
RGENDawes Karen ADirA - Grant$0.00+20,00075,764+36%+$00+1+15+15
2016-06-30
RGENRyan Thomas F JrDirS - Sale$26.60-5,00012,094-29%-$133,010-3-1+7+13
D
2016-06-28
RGENRyan Thomas F JrDirS - Sale+OE$24.59-10,00017,094-37%-$245,888+7+11+12+29
D
2016-06-28
RGENRyan Thomas F JrDirM - OptEx$3.22+5,00017,094+41%+$16,100+7+11+12+29
D
2016-06-27
RGENDawes Karen ADirM - OptEx$3.10+15,00055,764+37%+$46,500+7+10+15+32
D
2016-06-27
RGENDawes Karen ADirF - Tax$23.46-1,98255,764-3%-$46,498+7+10+15+32
D
2016-05-24
RGENBenjamin HowardVP Business DevelopmentM - OptEx$6.23+10,00028,626+54%+$62,300-4+2-4+31
D
2016-05-11
RGENRyan Thomas F JrDirA - Grant$0.00+1,76322,094+9%+$00-9-14+17
D
2016-05-11
RGENMuir Glenn PDirA - Grant$0.00+1,7631,763New+$00-9-14+17
D
2016-05-11
RGENCox JohnDirA - Grant$0.00+1,7633,621+95%+$00-9-14+17
D
2016-05-11
RGENCooper Glenn L MdDirA - Grant$0.00+1,76337,094+5%+$00-9-14+17
D
2016-05-11
RGENBarthelemy NicolasDirA - Grant$0.00+1,7632,782+173%+$00-9-14+17
D
2016-05-11
RGENDawes Karen ADirA - Grant$0.00+2,50542,746+6%+$00-9-14+17
2016-05-11
RGENBenjamin HowardVP Business DevelopmentS - Sale$26.72-2,88918,626-13%-$77,1990-9-14+17
2016-05-05
RGENHunt AnthonyCEOF - Tax$25.71-1,62273,342-2%-$41,7020-3-9-1
D
2016-02-29
RGENRusche James RSVPF - Tax$26.05-1,419100,516-1%-$36,965+6+6+4+22
D
2016-02-26
RGENRusche James RSVPA - Grant$0.00+5,086100,516+5%+$0+6+6+4+22
D
2016-02-29
RGENBenjamin HowardVP Business DevelopmentF - Tax$26.05-1,30221,515-6%-$33,917+6+6+4+22
D
2016-02-26
RGENBenjamin HowardVP Business DevelopmentA - Grant$0.00+6,26321,515+41%+$0+6+6+4+22
D
2016-02-29
RGENSnodgres JonCFOF - Tax$26.05-74817,777-4%-$19,485+6+6+4+22
D
2016-02-26
RGENSnodgres JonCFOA - Grant$0.00+7,90517,777+80%+$0+6+6+4+22
D
2016-02-29
RGENHunt AnthonyCEOF - Tax$26.05-2,26774,964-3%-$59,055+6+6+4+22
D
2016-02-26
RGENHunt AnthonyCEOA - Grant$0.00+33,58974,964+81%+$0+6+6+4+22

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top